Hopital Ambroise-Pare

Boulogne-Billancourt 92100

1 studies enrolling now · 4 studies all time

What they study most

Advanced Non-Small Cell Lung Cancer, Any Tumor Type Eligible for Treatment With Talimogene Laherparepvec in Amgen or BioVEX-sponsored Clinical Trial, Carcinoma, Basal Cell, Cutaneous Squamous Cell Carcinoma, Metastatic Non-Small Cell Lung Cancer

Studies at this site

• Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7 — Recruiting now
• Study of Adjuvant Cemiplimab Versus Placebo After Surgery and Radiation Therapy in Patients With High Risk Cutaneous Squamous Cell Carcinoma — Running, not enrolling
• PD-1 in Patients With Advanced Basal Cell Carcinoma Who Experienced Progression of Disease on Hedgehog Pathway Inhibitor Therapy, or Were Intolerant of Prior Hedgehog Pathway Inhibitor Therapy — Completed
• Registry Study for Talimogene Laherparepvec — Completed